Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant
Clinical trial NCT03821519 · UNKNOWN
Trial details
- NCT number
- NCT03821519
- Sponsor
- A.O. Ospedale Papa Giovanni XXIII
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-13
- Primary completion
- 2022-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.